|
Health Conditions
|
Parkinson's Disease
What is on the horizon?
Molecular science techniques, including gene therapy, stem cell technology, and stimulation of nerve growth factors, are the newest research areas being explored in the treatment of Parkinson's disease.
The National Institute of Neurological Disorders and Stroke is trying to establish effective therapies to slow the progression of Parkinson's disease. Research was conducted to see if Mirapex and Requip slow the progression of Parkinson's disease. The results showed that Requip minimally slowed down the progression of Parkinson's disease when it was compared to levodopa. During a 46 month period, patients initially treated with Mirapex also demonstrated a reduction in dopamine neuron degeneration compared with those initially treated with levodopa. More investigations are needed for a definite conclusion.
Recent studies have also shown that Coenzyme Q10 may be effective in slowing the progression of the Parkinson's disease. This discovery has opened doors for researchers to further investigate the effectiveness of Coenzyme Q10.
|
Note: The above information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist, or other healthcare professional. It is not intended to diagnose a health condition, but it can be used as a guide to help you decide if you should seek professional treatment or to help you learn more about your condition once it has been diagnosed.
|
|
What is on the horizon?
